Who We Fund
Since 1949, LLS has provided more than $1.8 billion to the best and the brightest blood cancer researchers and biotech companies to support their groundbreaking research. Meet grantees and the companies who’ve joined our fight to find cures and help blood cancer patients everywhere.
Gareth Morgan
smoldering myeloma, MGUS
F. Lennie Wong
Equity in Access
Carl June
CAR T immunotherapy
Nizar Bahlis
Myeloma immunotherapy
Brian Walker
smoldering myeloma, MGUS
Caribou Biosciences
immunotherapy, allo-CAR, NHL, MM, AML
Jonathan Licht
DNA biology, myeloma
Constantine Mitsiades
CAR-T and CAR-NK immunotherapies
Eugenio Morelli
Myeloma
Sigurður Kristinsson
Smoldering myeloma
Qing Yi
Novel CAR-T
Siegfried Janz
Myeloma immunotherapy
William Matsui
Myeloma
Alfred Garfall
myeloma immunotherapy
Ruben Carrasco
Myeloma
Suzanne Lentzsch
Myeloma
Jing Yang
Myeloma
Bruno Paiva
smoldering myeloma
Armin Rashidi
gut bacteria and transplant success
Jun Qi
Myeloma
Robert Orlowski
(Smoldering) Multiple Myeloma
Caroline Arber
myeloma CAR-T
Sham Mailankody
Myeloma immunotherapy clinical trials
Christopher Flowers
clinical trial access
Michaela Reagan
Multiple Myeloma
Tanya Siddiqi
clinical trial access
Jane Oliaro
Myeloma & Lymphoma Immunotherapy
Amin Sobh
Myeloma biology
Lev Kats
myeloma and epigenetics
Matteo Bellone
Smoldering multiple myeloma
Alec Zhang
myeloma, immunotherapy
Madhav Dhodapkar
multiple myeloma immunotherapy
Noemí Puig Morón
Myeloma
Peter Croucher
Multiple Myeloma
Simona Colla
Myeloma biology
John Leonard
lymphoma research
Jing Fu
myeloma
Mala Shanmugam
myeloma
Fenghuang Zhan
Myeloma and bone disease
Lawrence Boise
CART and myeloma
Ricky Johnstone
lymphoma and myeloma
Jianhua Yu
myeloma immunotherapy
Paul Beavis
immunotherapy in myeloma